These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31690146)

  • 1. An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery.
    Madani F; Hsein H; Busignies V; Tchoreloff P
    Pharm Dev Technol; 2020 Feb; 25(2):133-148. PubMed ID: 31690146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Formulation strategies of intraoral dosage forms].
    Kállai N; Sebestyén Z; Szabó B; Simon V; Antal I; Zelkó R
    Acta Pharm Hung; 2012; 82(3):95-103. PubMed ID: 23230648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Modified Drug Release Solid Dosage Form with Special Reference to Design; An Overview.
    Murugesan S; Gowramma B; Lakshmanan K; Reddy Karri VVS; Radhakrishnan A
    Curr Drug Res Rev; 2020; 12(1):16-25. PubMed ID: 31755398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization challenges and formulation strategies associated with oral biologic drug delivery systems.
    Truong-Le V; Lovalenti PM; Abdul-Fattah AM
    Adv Drug Deliv Rev; 2015 Oct; 93():95-108. PubMed ID: 26277263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges.
    Tlaxca JL; Ellis S; Remmele RL
    Adv Drug Deliv Rev; 2015 Oct; 93():56-78. PubMed ID: 25312673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability.
    Maderuelo C; Lanao JM; Zarzuelo A
    Eur J Pharm Sci; 2019 Oct; 138():105019. PubMed ID: 31374253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in oral delivery of peptide hormones.
    Varamini P; Toth I
    Expert Opin Drug Deliv; 2016; 13(4):507-22. PubMed ID: 26787260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
    Debotton N; Dahan A
    Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
    Wang SH; Thompson AL; Hickey AJ; Staats HF
    Curr Top Microbiol Immunol; 2012; 354():121-56. PubMed ID: 21822816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS; Purewal TS; Alpar OH
    J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in the formulation and delivery of spray dried vaccines.
    Kanojia G; Have RT; Soema PC; Frijlink H; Amorij JP; Kersten G
    Hum Vaccin Immunother; 2017 Oct; 13(10):2364-2378. PubMed ID: 28925794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in formulation and manufacturing strategies for the delivery of therapeutic proteins and peptides in orally disintegrating dosage forms.
    Bashir S; Fitaihi R; Abdelhakim HE
    Eur J Pharm Sci; 2023 Mar; 182():106374. PubMed ID: 36623699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compressed orally disintegrating tablets: excipients evolution and formulation strategies.
    Al-khattawi A; Mohammed AR
    Expert Opin Drug Deliv; 2013 May; 10(5):651-63. PubMed ID: 23387409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery systems and adjuvants for oral vaccines.
    Lavelle EC; O'Hagan DT
    Expert Opin Drug Deliv; 2006 Nov; 3(6):747-62. PubMed ID: 17076597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals.
    Vass P; Démuth B; Hirsch E; Nagy B; Andersen SK; Vigh T; Verreck G; Csontos I; Nagy ZK; Marosi G
    J Control Release; 2019 Feb; 296():162-178. PubMed ID: 30677436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral pulsatile delivery: rationale and chronopharmaceutical formulations.
    Maroni A; Zema L; Del Curto MD; Loreti G; Gazzaniga A
    Int J Pharm; 2010 Oct; 398(1-2):1-8. PubMed ID: 20655998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
    Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.
    Aleksovski A; Dreu R; Gašperlin M; Planinšek O
    Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.